Skip to main content

Magnitude of hepatitis B and C virus infections and associated factors among patients scheduled for surgery at Hawassa University comprehensive specialized Hospital, Hawassa City, southern Ethiopia



The aim of this study was to assess the magnitude of HBV and HCV infection and its associated factors among surgical patients at Hawassa University comprehensive specialized Hospital Hawassa City, southern Ethiopia.


In this study, the prevalence of HBsAg and Anti-HCV among patients scheduled for surgery were 9% and 5.5%, respectively. Patients who practiced multiple sexual partner (AOR = 2.58, CI 1.18–5.61), dental procedure (AOR = 4.20, CI 1.87–9.55) and blood transfusion (AOR = 3.84, CI 1.27–11.65) had higher odds of HBV infection and those who had history of surgical procedure (AOR = 6.05: 95% CI 1.59–23.04) and dental procedure (AOR = 3.70: 95% CI 1.40–9.77) had higher odds of HCV infection.


Viral hepatitis is an inflammation of the liver. Five different types of hepatitis viruses (A-E) are responsible for viral hepatitis [1]. Of these, hepatitis B viruses (HBV) and hepatitis C viruses (HCV) are the substantial cause of hepatitis around the globe [2].

HBV and HCV can be transmitted through contact with an infected person’s: blood, semen and body fluids [3]. Both HBV and HCV also transmitted through sexual intercourse and vertically from mother to child [4]. In medical care providing centers it is transmitted due to the reuse of inadequately sterilized medical equipment and through per-cutaneous inoculation [5]. Surgical procedures are also modes transmission and the staff may expose for hepatitis viruses [6]. In developing nation the nosocomial transmission of new HCV infections is a major health problem [7].

HBV and HCV infections causes serious health problem throughout the world. The burden is high in Asia, Africa, southern Europe and Latin America. HBV is highly contagious, 50–100 and 10 times more infectious than human immune deficiency virus (HIV) and HCV, respectively [8]. More than 240 and 150 million populations were affected by chronic liver disease due to HBV and HCV infection, respectively [9, 10].

The prevalence of chronic HBV infection varies widely due to geographical area, and predominant routes of transmission [11]. It varies widely, from high (≥ 8%) to intermediate (2–7%) and low (< 2%). Similarly HCV infection is high, moderate or low endemic when the prevalence is > 3.5%, 1.5–3.5% and < 1.5%, respectively [12].

In sub Saharan Africa the prevalence of HBV carriers ranges from 10 to 20% [13]. Ethiopia is one of the high burden countries with high prevalence of HBsAg (35.8%) and anti-HCV (22.5%) among chronic liver disease [14].

The prevalence of HBsAg and anti-HCV is high in hospitalized surgical patients. The risks of acquiring hepatitis diseases for medical waste cleaners after accidental sharp injuries were 30% for HBV and 3% for HCV [15].

In Ethiopia, particularly in the study site, there was no information concerning sero-prevalence of HBsAg and anti-HCV in patients scheduled for surgery. The finding of this study provides evidence for health planers and healthcare workers to take correct and appropriate intervention before and during handling of surgical patients.

Main text


A Hospital based cross-sectional study was conducted at Hawassa University comprehensive specialized hospital. This study was conducted from January to April 2018.

Patients who were appointed for any surgery during the study period and gave consent and assent to participate were included. And those patients who need urgent care in the ICU, on HIV treatment, took Vaccine for HBV, seriously ill and unable to be during interview were excluded.

The sample size was calculated using single population proportion formula based on the following assumptions; the required sample size (n) is estimated with a confidence level of 95%. And proportion of 50% and precision of 5%. A systematic random sampling method was used to recruit study participants.

Structured and pretested questionnaire was used to collect relevant information though interview, which was prepared by reviewing prior similar studies. The data was collected by two B.Sc. nurses.

About 5 ml of venous blood sample was collected from each study participant. Sera were tested for HBsAg marker using SD BIOLINE Strip Test (Standard Diagnostic Inc., Korea). The sensitivity and specificity of the test kit was > 99%. It also tested for Anti HCV using rapid test kit, (Biotest Biotech, China). The sensitivity and specificity of the Kit was 99.1% and 99.6%, respectively. Similarly it was tested for HBeAg using (HBeAg) (Insight HBeAg rapid test kit, TULIP DIAGNOSTICS, Germany). The sensitivity and specificity of the Kit was 99.1% and 99.6%, respectively.

The questionnaire was pre-tested on 5% of the calculated sample size. All data collectors were trained. The collected data were checked daily. The quality of test results were checked using the internal and external quality control.

Data was analyzed using SPSS version 23 software. Bivariate analysis was performed to select candidate variables. Variables with P-value < 0.25 were nominated for multivariable analysis. P-values < 0.05 was considered statistically significance.


A total of 422 study participants were enrolled in this study. Of these, 51.2% were males and 48.8% were females. The mean age was 35 years. The majority of the study participants (64.9%) were rural in residence and 27.3% had no formal education. Regarding to marital status (64.7%) was married (Additional file 1: Table S1 and Additional file 2: Table S2).

The overall prevalence of HBV and HCV were 9.0% (38/422) and 5.5% (23/422), respectively. Of these, only one patient (0.20%) was co-infected. Of, the HBs Ag positive cases, 34.2% of patients had evidence of HBeAg in their serum.

Exposure to different factors for HBV and HCV infection were presented in (Table 1). In multivariate analysis, multiple sexual partner (AOR = 2.58, CI 1.18–5.61), dental procedure (AOR = 4.20, CI 1.87–9.55) and blood transfusion (AOR = 3.84, CI 1.27–11.65) remained statistically significant factors associated with HBV infection.

Table 1 Bivariate and multivariate analysis of factors associated with HBV infection among patients scheduled for surgery at Hawassa University Comprehensive Specialized Hospital, southern Ethiopia, 2018

In further analysis, the risk of having HCV infection remained significantly higher in patients who had history of surgical procedure (AOR = 6.05: 95% CI 1.59–23.04) and dental procedure (AOR = 3.70: 95% CI 1.40–9.77) as compared to their counterparts (Table 2).

Table 2 Bivariate and multivariate analysis of factors associated with HCV infection among patients scheduled for surgery at Hawassa University Comprehensive Specialized Hospital, southern Ethiopia, 2018


In this study, the prevalence of HBsAg and Anti- HCV among patients scheduled for surgery at HUCSH were 9% [95% confidence interval (CI) 6.4–11.8%] and 5.5% [95% confidence interval (CI) 3.3–7.6%], respectively. This makes the study sites as high endemic area for both HBV and HCV infection according to WHO criteria [12]. This was in agreement with results reported in similar study population in Pakistan (9.33%) [16]. In contrast, lower prevalence was reported in a study conducted in Sudan (4.91%) [17].

Although direct comparison is difficult because of difference in study population, the sero-prevalence in the current study was in agreement with a previous study reported among pregnant women in Hawassa Ethiopia with a prevalence of (7.8%) [18], in systematic review and meta-analysis done in Ethiopia: blood donors (8.4%) and community based studies (8.0%) [19]. It is also consistent with a (3.7%) prevalence in a study conducted in Addis Ababa [20] and (5%) in Jimma, Ethiopia [21].

Furthermore, the rate of Anti-HCV among patients scheduled for surgery at HUCSH was in agreement with results reported in similar study population in Pakistan (5.1%) [22]. Higher prevalence were also reported in Pakistan (9.09%) [23]. And lower result was also reported in Iraq (0.4%) [24]. In contrast, unusual high HCV prevalence was reported in Bahir Dar (13.3%) [25]. The difference in the rate of HBsAg and Anti-HCV may be due to diverse risk factors involved in various geographical regions and different diagnostic methods employed. There are studies that used more sensitive laboratory methods (ELISA and PCR) compared to the rapid diagnostic test employed in the present study.

In this study, the prevalence of HBeAg among HBsAg positive individuals was (34.2%). Consistent finding was also reported in Nigeria [26]. The presence of HBeAg in the serum of patients with hepatitis B virus is a reflection of active viral replication in hepatocytes and is considered a surrogate marker for the presence of the DNA [27]. This reflects a pool of individuals who are highly infectious and serve in sustaining viral transmission and evolution in the population and health care providers.

Studies showed that due to sharing of similar transmission route, co-infection with HBV and HCV was common. However, only one patient (0.2%) was co-infected in this study. This finding agree in a study [23]. Co-infection of chronic HBV and HCV seems to result in more severe liver disease and risk of liver cancer [28]. The difference in the magnitude might be attributable to difference in the study population, geographical variation, and difference in methodology.

In this study, patients who had history of dental procedure had a fourfold higher chance of acquiring HBV and HCV infection. This finding was also supported by a study [29]. The higher prevalence in those who practiced might be due to most of the dental practices were done out of health institutions with unhygienic conditions and without proper sterilization.

Surgical patients who practiced sex with multiple sexual partners had higher odds of HBV infection compared to their counterparts. Similar findings was reported in in Nigeria [30]. The high prevalence rate may be due to the fact that, Hepatitis B virus infection is sexually transmitted and the transmission increases with the duration of sexual activity and number of sexual partners.

In this study, surgical patients who had history of blood transfusion had about 3.8 times higher odds of HBV infection, compared to their counterparts. The significant association of having history of blood transfusion with HBV infection was also documented in Nigeria [31]. The possible explanation for significant association between HBV infection and blood transfusion might be lack of improved laboratory screening methods of HBV infection from blood donors before transfusion in Ethiopia.

In this study, patients who had history of surgical procedure had six times higher odds of infection with HCV than patients who had no history of surgical procedure. This finding was similar with study conducted in Pakistan [23]. The may be due to the fact that lack of routine serological screening prior to surgery which is one of the factors responsible for increased disease transmission and re-use of contaminated syringes, surgical instruments and improperly screened blood products [32].


High prevalence of Hepatitis B and C virus infection was observed among patients scheduled for surgery in the study area. Therefore routine screening of all surgical patients before surgery and surgical procedures could be strictly followed, give health education to the community and minister of Health include screening program for all patients before surgery.


First, screening of only surgical patients for HBV and HCV couldn’t determine the exact rate of transmission from patients to HCW or vice versa. Second, due to budget and lack of facility ELISA, HBcAb tests and PCR tests were not done.

Availability of data and materials

There is no remaining data and materials, all information is clearly presented in the main manuscript.



hepatitis B virus


hepatitis C virus


hepatocellular carcinoma


Hawassa University comprehensive specialized hospital


intensive care unit


World Health Organization


  1. 1.

    Organization, W. H. Prevention and control of viral hepatitis infection: framework for global action. Geneva: WHO; 2012.

    Google Scholar 

  2. 2.

    Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepatitis. 2004;11:97–107.

    CAS  Article  Google Scholar 

  3. 3.

    Sacks FM, Pfeffer MA, Moye LA, Rouleau JL, Rutherford JD, Cole TG, Brown L, Warnica JW, Arnold JMO, Wun C-C. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med. 1996;335:1001–9.

    CAS  Article  Google Scholar 

  4. 4.

    Edwards DJ, Coppens DG, Prasad TL, Rook LA, Iyer JK. Access to hepatitis C medicines. Bull World Health Organ. 2015;93:799–805.

    Article  Google Scholar 

  5. 5.

    Ford DA. Implementing AORN recommended practices for sharps safety. AORN J. 2014;99:106–20.

    Article  Google Scholar 

  6. 6.

    Mele A, Spada E, Sagliocca L, Ragni P, Tosti ME, Gallo G, Moiraghi A, Balocchini E, Sangalli M, Lopalco PL. Risk of parenterally transmitted hepatitis following exposure to surgery or other invasive procedures: results from the hepatitis surveillance system in Italy. J Hepatol. 2001;35:284–9.

    CAS  Article  Google Scholar 

  7. 7.

    Gustot T, Fernandez J, Garcia E, Morando F, Caraceni P, Alessandria C, Laleman W, Trebicka J, Elkrief L, Hopf C. Clinical course of acute-on-chronic liver failure syndrome and effects on prognosis. Hepatology. 2015;62:243–52.

    Article  Google Scholar 

  8. 8.

    Pungpapong S, Kim WR, Poterucha JJ. Natural history of hepatitis B virus infection: an update for clinicians. Mayo Clin Proc. 2007;82:967–75.

    CAS  Article  Google Scholar 

  9. 9.

    Lazarus J. Global policy report on the prevention and control of viral hepatitis in WHO Member States. Geneva: WHO; 2014.

    Google Scholar 

  10. 10.

    Kim H, Shin AR, Chung HH, Kim MK, Lee JS, Shim J-J, Kim B-H. Recent trends in hepatitis B virus infection in the general Korean population. Korean J Int Med. 2013;28:413.

    Article  Google Scholar 

  11. 11.

    Maddrey WC. Hepatitis B: an important public health issue. J Med Virol. 2000;61:362–6.

    CAS  Article  Google Scholar 

  12. 12.

    Organization WH. Protocol for assessing prevalence of Hepatitis B infection in antenatal patients. Protocol for assessing prevalence of hepatitis B infection in antenatal patients. Geneva: World Health Organization; 1990.

    Google Scholar 

  13. 13.

    Kramvis A, Kew MC. Epidemiology of hepatitis B virus in Africa, its genotypes and clinical associations of genotypes. Hepatol Res. 2007;37:S9–19.

    Article  Google Scholar 

  14. 14.

    Ayele AG, Gebre-Selassie S. Prevalence and risk factors of hepatitis B and hepatitis C virus infections among patients with chronic liver diseases in public hospitals in Addis Ababa. ISRN Trop Med: Ethiopia; 2013. p. 2013.

    Google Scholar 

  15. 15.

    Prüss-Üstün A, Rapiti E, Hutin Y. Estimation of the global burden of disease attributable to contaminated sharps injuries among health-care workers. Am J Ind Med. 2005;48(482–490):7.

    Google Scholar 

  16. 16.

    Umar M, Tul Bushra H, Ahmad M, Ahmad M, Khurram M, Usman S, Arif M, Adam T, Minhas Z, Arif A. Hepatitis C in Pakistan: a review of available data. Hepat Monthly. 2010;10:205.

    Google Scholar 

  17. 17.

    Osman E-AI, Abdulrahman NA, Abbass O, Omer WH, Saad HA, Hamid MMA. Prevalence of Hepatitis B surface antigen and Hepatitis C virus antibodies among pre-surgery screened patients in Khartoum, Central Sudan. J Gen Mol Virol. 2012;4:6–9.

    Article  Google Scholar 

  18. 18.

    Metaferia Y, Dessie W, Ali I, Amsalu A. Seroprevalence and associated risk factors of hepatitis B virus among pregnant women in southern Ethiopia: a hospital-based cross-sectional study. Epidemiol Health. 2016;38:e2016027.

    Article  Google Scholar 

  19. 19.

    Belyhun Y, Maier M, Mulu A, Diro E, Liebert UG. Hepatitis viruses in Ethiopia: a systematic review and meta-analysis. BMC Infect Dis. 2016;16:761.

    Article  Google Scholar 

  20. 20.

    Duncan ME, Tibaus G, Pelfer A, Mehari L, Petine PL, Peutherer J, Young H, Jamil Y, Darougor S. Prevalence and significance of sexually transmitted diseases among Ethiopian women attending antenatal clinics in Addis Ababa. Ethiop J Health Dev. 1995;9:31–40.

    Google Scholar 

  21. 21.

    Awole M, Gebre-Selassie S. Seroprevalence of HBsAg and its risk factors amoung pregnant women in Jimma, Southwest Ethiopia. Ethiop J Health Dev. 2005;19:45–50.

    Article  Google Scholar 

  22. 22.

    Ali SA, Shah FA, Ahmed K. Prevalence of hepatitis B and C virus in surgical patients. Pak J Surg. 2007;23:109–12.

    Google Scholar 

  23. 23.

    Javed K, Ishrat Z, Sultana N. Hepatitis C is more common than hepatitis B among surgical patients and previous surgery is the most common risk factor. Blood Transfusion. 2006;50(4):32.

    Google Scholar 

  24. 24.

    Lavanchy D. Evolving epidemiology of hepatitis C virus. Clin Microbiol Infect. 2011;17:107–15.

    CAS  Article  Google Scholar 

  25. 25.

    Berhe H, Yismaw G, Addis Z, Slassie H, Anagaw B, Unakal C. Seroprevalence and associated risk factors of human immunodeficiency virus and hepatitis B virus infections among prison inmates. J Pharm Biomed Sci. 2013;30:1035–45.

    Google Scholar 

  26. 26.

    Mbaawuaga E, Enenebeaku M, Okopi J. Hepatitis B virus (HBV) infection among pregnant women in Makurdi, Nigeria. Afr J Biomed Res. 2008;11:155–9.

    Google Scholar 

  27. 27.

    Shen F-C, Su I-J, Wu H-C, Hsieh Y-H, Yao W-J, Young K-C, Chang T-C, Hsieh H-C, Tsai H-N, Huang W. A pre-S gene chip to detect pre-S deletions in hepatitis B virus large surface antigen as a predictive marker for hepatoma risk in chronic hepatitis B virus carriers. J Biomed Sci. 2009;16:84.

    Article  Google Scholar 

  28. 28.

    Konstantinou D, Deutsch M. The spectrum of HBV/HCV coinfection: epidemiology, clinical characteristics, viralinteractions and management. Ann Gastroenterol. 2015;28:221.

    PubMed  PubMed Central  Google Scholar 

  29. 29.

    Memon MR, Shaikh AA, Soomro AA, Arshad S, Shah QA. Frequency of hepatitis B and C in patients undergoing elective surgery. J Ayub Med Coll Abbott. 2010;22:167–70.

    Google Scholar 

  30. 30.

    Onwuakor C, Eze V, Nwankwo I, Iwu J. Sero-prevalence of hepatitis B surface antigen (HBsAg) amongst pregnant women attending antenatal clinic at the federal medical centre Umuahia, Abia State, Nigeria. Am J Public Health Res. 2014;2:255–9.

    Article  Google Scholar 

  31. 31.

    Ezechi OC, Kalejaiye OO, Gab-Okafor CV, Oladele DA, Oke BO, Musa ZA, Ekama SO, Ohwodo H, Agahowa E, Gbajabiamilla T. Sero-prevalence and factors associated with Hepatitis B and C co-infection in pregnant Nigerian women living with HIV Infection. Pan Afr Med J. 2014;17:197.

    Article  Google Scholar 

  32. 32.

    Ott J, Stevens G, Groeger J, Wiersma S. Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine. 2012;30:2212–9.

    CAS  Article  Google Scholar 

Download references


The authors extend their appreciation to the Hawassa University Comprehensive specialized Hospital for providing us all the support needed during data collection. The authors are also grateful to the study participants who took part in the study.


No funding was obtained.

Author information




MT DD and AA designed the study; SH and MT performed the statistical analyses. All authors contributed to interpretation, the write-up. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Siraj Hussen.

Ethics declarations

Ethics approval and consent to participate

Ethical approval was obtained from the Institutional Review Board of College of Medicine and Health Sciences, Hawassa University. The purpose and importance of the study were explained to each study participants. To ensure confidentiality of participant’s codes numbers was used on the questionnaire. To ensure the voluntary participation of the study participants, informed written consent and assent was obtained from each study participants. Participant was interviewed alone to keep the privacy. All participants were not paid for the test.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Additional files

Additional file 1: Table S1.

Questionnaire: to investigate the risk factor for hepatitis B virus and hepatitis C virus in, Hawassa University comprehensive specialized hospital, Hawassa, Ethiopia.

Additional file 2.

Distribution of HCV by socio-demographic characteristics of study participants scheduled for surgery at Hawassa, University comprehensive specialized Hospital, southern Ethiopia, 2018.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (, which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Taye, M., Daka, D., Amsalu, A. et al. Magnitude of hepatitis B and C virus infections and associated factors among patients scheduled for surgery at Hawassa University comprehensive specialized Hospital, Hawassa City, southern Ethiopia. BMC Res Notes 12, 412 (2019).

Download citation


  • Hepatitis B virus
  • Hepatitis C virus
  • Surgical patients
  • Ethiopia